Time to Spare Newly Diagnosed Non Transplant Eligible Myeloma (eNDMM) from Thalidomide
Hélène Demarquette(Ikerbasque), Xavier Leleu(Inserm), Cristina João(Universidade Nova de Lisboa), Thierry Façon(Université de Lille), Laurent Garderet(Inserm), Lionel Karlin(Hôpital Lyon Sud), Francesca Gay(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Katell Le Dû(Clinique Victor Hugo), Evangelos Terpos(National and Kapodistrian University of Athens), Charles Lancesseur(Centre Hospitalier Universitaire de Caen Normandie), Artur Jurczyszyn(Jagiellonian University), Stéphanie Guidez(Inserm), Laurent Voillat, Brigitte Pegourié(Centre Hospitalier Universitaire de Grenoble), Niels Abildgaard(University of Southern Denmark), Laurence Legros(Hôpital l'Archet), Margaret Macro(Hôpital Cochin), Denis Caillot, Bruno Royer(Centre Hospitalier Universitaire Amiens-Picardie), Sonja Zweegman(Vrije Universiteit Amsterdam), Souhila Ikhlef(Sorbonne Université), Cyrille Hulin(Hôpital Cardiologique du Haut-Lévêque), Philippe Moreau(Centre National de la Recherche Scientifique), Marie Lorraine Chrétien(CHU Dijon Bourgogne), Anne‐Marie Stoppa(Institut Paoli-Calmettes), Lofti Benboubker(Centre Hospitalier Universitaire de Tours), Anne Banos(Centre Hospitalier de la Côte Basque), Martine Escoffre(Institute Cancer De La Loire Lucien Neuwirth), Claire Bories(Guy's and St Thomas' NHS Foundation Trust), Éric Voog(Centre Jean Bernard)
Cited by 0
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Hematological findings and complications of <scp>COVID</scp>‐19
|American Journal of Hematology|2020|1.7k
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
|New England Journal of Medicine|2020|1.5k